http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2095430-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 1991-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e1ec8640618f9b12fd1abbcb10afb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9caae14df799c3ec09d9dc2fb777c7
publicationDate 1992-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2095430-A1
titleOfInvention 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
abstract The present invention concerns 2-decarboxyl-2-aminoalkyl derivatives of naturally occurring and synthetic prostaglandins, N-substituted derivatives, ester prodrugs and homologues of such compounds that are potent ocular hypotensives, and are particularly suitable for the management of glaucoma.
priorityDate 1990-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415867324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18522661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID182180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452280402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425772305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 46.